MedPath

A clinical study to evaluate the usefulness of mobile phones in improving TB treatment

Phase 3
Conditions
Health Condition 1: null- Tuberculosis and Tuberculosis and HIV coinfected individuals
Registration Number
CTRI/2011/07/001889
Lead Sponsor
niversity of New South Wales
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
500
Inclusion Criteria

1. Owns a mobile phone and can read text messages

2. Person with confirmed TB ( smear and/or culture)

3. Person having both TB and HIV disease

4. Should be able to sign an informed consent

Exclusion Criteria

Not able to sign the informed consent document

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Treatment Adherence ratesTimepoint: Baseline, 3 and 6 months
Secondary Outcome Measures
NameTimeMethod
1.Treatment completion and cure rates <br/ ><br>2.Treatment success rates <br/ ><br>3.Adverse drug reaction rates <br/ ><br>4.Stigma associated with TB (measured by a validated survey) <br/ ><br>5.Patient satisfaction (measured by a validated survey) <br/ ><br>6.Usage of the m-health initiative <br/ ><br>Timepoint: Baseline, 3 and 6 months
© Copyright 2025. All Rights Reserved by MedPath